BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 10455406)

  • 1. Development of a modified selective amplifier gene for hematopoietic stem cell gene therapy.
    Matsuda KM; Kume A; Ueda Y; Urabe M; Hasegawa M; Ozawa K
    Gene Ther; 1999 Jun; 6(6):1038-44. PubMed ID: 10455406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A selective amplifier gene for tamoxifen-inducible expansion of hematopoietic cells.
    Xu R; Kume A; Matsuda KM; Ueda Y; Kodaira H; Ogasawara Y; Urabe M; Kato I; Hasegawa M; Ozawa K
    J Gene Med; 1999; 1(4):236-44. PubMed ID: 10738556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo expansion of gene-modified hematopoietic cells by a novel selective amplifier gene utilizing the erythropoietin receptor as a molecular switch.
    Nagashima T; Ueda Y; Hanazono Y; Kume A; Shibata H; Ageyama N; Terao K; Ozawa K; Hasegawa M
    J Gene Med; 2004 Jan; 6(1):22-31. PubMed ID: 14716674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo selective expansion of gene-modified hematopoietic cells in a nonhuman primate model.
    Hanazono Y; Nagashima T; Takatoku M; Shibata H; Ageyama N; Asano T; Ueda Y; Dunbar CE; Kume A; Terao K; Hasegawa M; Ozawa K
    Gene Ther; 2002 Aug; 9(16):1055-64. PubMed ID: 12140733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A G-CSF receptor-gyrase B fusion gene: A new type of molecular switch for expansion of genetically modified hematopoietic cells.
    Kume A; Ito K; Ueda Y; Hasegawa M; Urabe M; Mano H; Ozawa K
    Biochem Biophys Res Commun; 1999 Jun; 260(1):9-12. PubMed ID: 10381335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a novel selective amplifier gene for controllable expansion of transduced hematopoietic cells.
    Ito K; Ueda Y; Kokubun M; Urabe M; Inaba T; Mano H; Hamada H; Kitamura T; Mizoguchi H; Sakata T; Hasegawa M; Ozawa K
    Blood; 1997 Nov; 90(10):3884-92. PubMed ID: 9354655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expansion of genetically corrected neutrophils in chronic granulomatous disease mice by cotransferring a therapeutic gene and a selective amplifier gene.
    Hara T; Kume A; Hanazono Y; Mizukami H; Okada T; Tsurumi H; Moriwaki H; Ueda Y; Hasegawa M; Ozawa K
    Gene Ther; 2004 Sep; 11(18):1370-7. PubMed ID: 15229634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo expansion of transduced murine hematopoietic cells with a selective amplifier gene.
    Kume A; Koremoto M; Xu R; Okada T; Mizukami H; Hanazono Y; Hasegawa M; Ozawa K
    J Gene Med; 2003 Mar; 5(3):175-81. PubMed ID: 12666183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly efficient gene transfer into preterm CD34 hematopoietic progenitor cells.
    Shields LE; Kiem HP; Andrews RG
    Am J Obstet Gynecol; 2000 Sep; 183(3):732-7. PubMed ID: 10992201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteolytic cleavage of granulocyte colony-stimulating factor and its receptor by neutrophil elastase induces growth inhibition and decreased cell surface expression of the granulocyte colony-stimulating factor receptor.
    Hunter MG; Druhan LJ; Massullo PR; Avalos BR
    Am J Hematol; 2003 Nov; 74(3):149-55. PubMed ID: 14587040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection and growth regulation of genetically modified cells with hapten-specific antibody/receptor tyrosine kinase chimera.
    Tanaka K; Kawahara M; Ueda H; Nagamune T
    Biotechnol Prog; 2009; 25(4):1138-45. PubMed ID: 19569211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diverse isoforms of colony-stimulating factor-1 have different effects on the development of stroma-dependent hematopoietic cells.
    Friel J; Heberlein C; Geldmacher M; Ostertag W
    J Cell Physiol; 2005 Jul; 204(1):247-59. PubMed ID: 15744782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fanconi anemia and beta c deficiency-associated pulmonary alveolar proteinosis as two hereditary diseases of childhood which are potentially curable by stem cell gene therapy but require different therapeutic approaches.
    Dirksen U; Moritz T; Burdach S; Flasshove M; Hanenberg H
    Klin Padiatr; 1999; 211(4):329-35. PubMed ID: 10472572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced antitumoral effect of adenovirus-mediated cytosine deaminase gene therapy by induction of antigen-presenting cells through stem cell factor/granulocyte-macrophage colony-stimulating factor gene transfer.
    Cao X; Huang X; Ju DW; Zhang W; Hamada H; Wang J
    Cancer Gene Ther; 2000 Feb; 7(2):177-86. PubMed ID: 10770625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene transfer into nonhuman primate hematopoietic stem cells: implications for gene therapy.
    Hanazono Y; Terao K; Ozawa K
    Stem Cells; 2001; 19(1):12-23. PubMed ID: 11209087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of retroviral transduction efficiency in CD34+ cells derived from bone marrow versus G-CSF-mobilized or G-CSF plus stem cell factor-mobilized peripheral blood in nonhuman primates.
    Hematti P; Tuchman S; Larochelle A; Metzger ME; Donahue RE; Tisdale JF
    Stem Cells; 2004; 22(6):1062-9. PubMed ID: 15536196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor.
    Bruns I; Steidl U; Fischer JC; Czibere A; Kobbe G; Raschke S; Singh R; Fenk R; Rosskopf M; Pechtel S; von Haeseler A; Wernet P; Tenen DG; Haas R; Kronenwett R
    Haematologica; 2008 Mar; 93(3):347-55. PubMed ID: 18268278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocyte colony-stimulating factor/granulocyte colony-stimulating factor receptor biological axis promotes survival and growth of bladder cancer cells.
    Chakraborty A; Guha S
    Urology; 2007 Jun; 69(6):1210-5. PubMed ID: 17572226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STAT3-mediated differentiation and survival and of myeloid cells in response to granulocyte colony-stimulating factor: role for the cyclin-dependent kinase inhibitor p27(Kip1).
    de Koning JP; Soede-Bobok AA; Ward AC; Schelen AM; Antonissen C; van Leeuwen D; Löwenberg B; Touw IP
    Oncogene; 2000 Jul; 19(29):3290-8. PubMed ID: 10918585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent low-level engraftment of rhesus peripheral blood progenitor cells transduced with the fanconi anemia C gene after conditioning with low-dose irradiation.
    Kang EM; Hanazano Y; Frare P; Vanin EF; De Witte M; Metzger M; Liu JM; Tisdale JF
    Mol Ther; 2001 Jun; 3(6):911-9. PubMed ID: 11407905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.